Cumberland Pharmaceuticals Inc. Payments of Debt Issuance Costs
Cumberland Pharmaceuticals Inc. (CPIX) reported Payments of Debt Issuance Costs of $52.50 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2019-11-13
- 2019-09-30: Payments of Debt Issuance Costs 9 month $52.50K.
- 2018-09-30: Payments of Debt Issuance Costs 9 month $0.00.
| Period end | Payments of Debt Issuance Costs 9 month |
|---|---|
| 2019-09-30 | $52.50K 10-Q · filed 2019-11-13 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |